Biblio
“APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points.”, J Alzheimers Dis, vol. 69, no. 3, pp. 783-793, 2019.
, “APOE ɛ4 Carriers Show Delayed Recovery of Verbal Memory and Smaller Entorhinal Volume in the First Year After Ischemic Stroke.”, J Alzheimers Dis, vol. 71, no. 1, pp. 245-259, 2019.
, “Association between Adipokines and Biomarkers of Alzheimer's Disease: A Cross-Sectional Study.”, J Alzheimers Dis, vol. 67, no. 2, pp. 725-735, 2019.
, “The Association between Mushroom Consumption and Mild Cognitive Impairment: A Community-Based Cross-Sectional Study in Singapore.”, J Alzheimers Dis, vol. 68, no. 1, pp. 197-203, 2019.
, “Association of Cognitive Function with Amyloid-β and Tau Proteins in the Vitreous Humor.”, J Alzheimers Dis, vol. 68, no. 4, pp. 1429-1438, 2019.
, “A Brief Ischemic Postconditioning Protects Against Amyloid-β Peptide Neurotoxicity by Downregulating MLK3-MKK3/6-P38MAPK Signal in Rat Hippocampus.”, J Alzheimers Dis, vol. 71, no. 2, pp. 671-684, 2019.
, “Can Subjective Memory Complaints Identify Aβ Positive and Aβ Negative Amnestic Mild Cognitive Impairment Patients?”, J Alzheimers Dis, vol. 70, no. 4, pp. 1103-1111, 2019.
, “CD14 and Toll-Like Receptor 4 Promote Fibrillar Aβ42 Uptake by Microglia Through A Clathrin-Mediated Pathway.”, J Alzheimers Dis, vol. 68, no. 1, pp. 323-337, 2019.
, “Cerebral Amyloid Angiopathy and Neuritic Plaque Pathology Correlate with Cognitive Decline in Elderly Non-Demented Individuals.”, J Alzheimers Dis, vol. 67, no. 1, pp. 411-422, 2019.
, “Cerebral Microbleeds Are Associated with Cerebral Hypoperfusion in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 71, no. 1, pp. 273-280, 2019.
, “Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease?”, J Alzheimers Dis, vol. 69, no. 3, pp. 663-669, 2019.
, “Choroid Plexus Acts as Gatekeeper for TREM2, Abnormal Accumulation of ApoE, and Fibrillary Tau in Alzheimer's Disease and in Down Syndrome Dementia.”, J Alzheimers Dis, vol. 69, no. 1, pp. 91-109, 2019.
, “Circulating and Extracellular Vesicles Levels of N-(1-Carboxymethyl)-L-Lysine (CML) Differentiate Early to Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 69, no. 3, pp. 751-762, 2019.
, “The Clinical Phenotype of Vascular Cognitive Impairment in Patients with Type 2 Diabetes Mellitus.”, J Alzheimers Dis, vol. 68, no. 1, pp. 311-322, 2019.
, “A Clinical Trial of Transcranial Electromagnetic Treatment in Alzheimer's Disease: Cognitive Enhancement and Associated Changes in Cerebrospinal Fluid, Blood, and Brain Imaging.”, J Alzheimers Dis, vol. 71, no. 1, pp. 57-82, 2019.
, “Clinico-Neuropathological Findings in the Oldest Old from the Georgia Centenarian Study.”, J Alzheimers Dis, vol. 70, no. 1, pp. 35-49, 2019.
, “A Comparison of Partial Volume Correction Techniques for Measuring Change in Serial Amyloid PET SUVR.”, J Alzheimers Dis, vol. 67, no. 1, pp. 181-195, 2019.
, “Developing Effective Alzheimer's Disease Therapies: Clinical Experience and Future Directions.”, J Alzheimers Dis, vol. 71, no. 3, pp. 715-732, 2019.
, “Dietary Patterns and Cognitive Health in Older Adults: A Systematic Review.”, J Alzheimers Dis, vol. 67, no. 2, pp. 583-619, 2019.
, “Distinctive Neurochemistry in Alzheimer's Disease via 7 T In Vivo Magnetic Resonance Spectroscopy.”, J Alzheimers Dis, vol. 68, no. 2, pp. 559-569, 2019.
, “Early-Stage Alzheimer's Disease Is Associated with Simultaneous Systemic and Central Nervous System Dysregulation of Insulin-Linked Metabolic Pathways.”, J Alzheimers Dis, vol. 68, no. 2, pp. 657-668, 2019.
, “Education Moderates the Relation Between APOE ɛ4 and Memory in Nondemented Non-Hispanic Black Older Adults.”, J Alzheimers Dis, vol. 72, no. 2, pp. 495-506, 2019.
, “Effect of Advanced Glycation End Products on the Progression of Alzheimer's Disease.”, J Alzheimers Dis, vol. 72, no. 1, pp. 191-197, 2019.
, “The Effects of APOE4 on Mitochondrial Dynamics and Proteins in vivo.”, J Alzheimers Dis, vol. 70, no. 3, pp. 861-875, 2019.
, “Ethical Issues in the Treatment of Late-Stage Alzheimer's Disease.”, J Alzheimers Dis, vol. 68, no. 4, pp. 1311-1316, 2019.
,